Michael W Bonney

Bonney is currently executive chair of the board of Kaleido Buiosciences Inc., having served as CEO and chairman until 2018. Previously, he was a partner of Third Rock Ventures LLC, and was president and CEO of Cubist Pharmaceuticals Inc. He held executive positions at Biogen Inc. from 1995 to 2001 and was with Zeneca Pharmaceuticals for 11 years A member of the Bates board since 2002, Bonney is president and chief executive officer of Cubist Pharmaceuticals Inc. in Lexington, Mass. Since graduating from Bates with a degree in economics, he has established an outstanding business career in the biopharmaceuticals field while providing substantial service to Bates and to various community organizations. Bonney began his career with Zeneca Pharmaceuticals, holding positions of increasing responsibility in sales, marketing and strategic planning over the course of 11 years. In 1995 he joined Biogen Inc., ultimately serving as vice president for sales and marketing. He joined Cubist in 2002 as president and chief operating officer, and has been president, chief executive officer and a member of the Board of Directors since 2003. Bonney also serves on the Board of Trustees of the Beth Israel Deaconess Medical Center in Boston and is a former board member of the Biotechnology Industry Organization. Last year he became a board member of the Pharmaceutical Research and Manufacturers of America. Bonney and his family have many strong connections to Bates. His father, sister, wife and oldest daughter are all Bates graduates. His grandfather attended Bates and his youngest daughter is a member of the class of 2012. Bonney has been very active in his class fundraising activities, with the Career Development Center and with the Office of Admissions. Both Bonney and his wife, Alison Grott Bonney ’80, served on their 10th Reunion Gift Committee and more recently as chairs of the Parents Fund.